| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $87.8M | +27.2% |
| SG&A Expense | $31.9M | +31.5% |
| Operating Income | -$119.7M | -28.3% |
| Pre-tax Income | -$104.2M | -20.0% |
| Income Tax | $0 | — |
| Net Income | -$104.2M | -20.0% |
| EPS (Basic) | -$0.48 | -9.1% |
| EPS (Diluted) | -$0.48 | -9.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $101.1M | -23.7% |
| Short-term Investments | $559.9M | -11.5% |
| Current Assets | $667.3M | -13.6% |
| Total Assets | $672.1M | -13.4% |
| Current Liabilities | $13.2M | -22.2% |
| Total Liabilities | $17.1M | -43.4% |
| Stockholders' Equity | $655.1M | -12.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$96.1M | -40.9% |
| Investing Cash Flow | $63.5M | +114.0% |
| Financing Cash Flow | $1.3M | -99.8% |